Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2003
07/02/2003CN1113096C New stromal cell lines from human bone marrow and their use
07/02/2003CN1113068C Materials for production of nanometer structure and use thereof
07/02/2003CN1112943C Gas driven gene delivery instrument
07/02/2003CN1112933C Anti-fungal methods and materials
07/02/2003CN1112855C Process for stabilizing proteins in acidic environment with high-ester pectin
07/01/2003USRE38169 Attaching ligands such as tristabilin which contains amide linked benzodipyrrole rings substituted with hydroxy and methoxy groups; permitting smaller doses
07/01/2003USH2074 Fertile transgenic corn plants
07/01/2003USH2071 Streptococcus pneumoniae gene HI0454
07/01/2003USH2070 Streptococcus pneumoniae gene sequence for DNA ligase
07/01/2003US6587805 Testing a write transducer as a reader
07/01/2003US6586661 Regulation of quinolate phosphoribosyl transferase expression by transformation with a tobacco quinolate phosphoribosyl transferase nucleic acid
07/01/2003US6586658 Modification of fatty acid metabolism in plants
07/01/2003US6586657 Methods for enhancing disease resistance in plants
07/01/2003US6586656 Transgenic rodents harboring APP allele having Swedish mutation
07/01/2003US6586655 Expression of human estrogen receptors in transgenic mice
07/01/2003US6586585 Isolating nucleic acids from a sample by passing polyacrylamide gel through a device which has a porous layer whose pore size decreases in the direction of sample passage; extraction using filtrate having a viscosity lower than sample
07/01/2003US6586584 Nucleotide sequences or primers derived from untranslated regions of flavivirus genomes used as detectors or for quantitative analysis
07/01/2003US6586583 Recombinant DNA molecule comprising regulatory sequence in combination with a heterologous plant promoter and structural gene; use in pulp and paper bleaching, waste destruction, soil remediation, organic synthesis
07/01/2003US6586582 Human GABA receptor proteins and polynucleotides encoding the same
07/01/2003US6586578 Deformylase (def1); isolated polynucleotide of given sequence; detects Staphylococcus aureus; can use to screen for antibiotics
07/01/2003US6586577 Nucleotide sequences coding veterbrate telomere binding protein for use in the treatment of cancer and aging
07/01/2003US6586575 Purification of somatotropin from transformed microorganisms
07/01/2003US6586571 Isolated polypeptide that binds to MORT-1 (mediators of receptor toxicity) protein
07/01/2003US6586569 Endometriosis-associated gene
07/01/2003US6586524 Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier
07/01/2003US6586412 Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
07/01/2003US6586410 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
07/01/2003US6586397 Polypeptides encoding tyrosine kinase containing immunoglobulin and endithelial growth factor homology domains; induce vascularization
07/01/2003US6586396 Subcutaneous administration of natriuretic peptide
07/01/2003US6586395 Apoptosis-modulating proteins
07/01/2003US6586392 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins
07/01/2003US6586365 Method for reducing pest damage to corn by treating transgenic corn seeds with clothianidin pesticide
07/01/2003US6586252 Nucleic acid molecule encoding the catalytic subunit of a protein phosphatase 2A that regulates flowering time in plants
07/01/2003US6586251 Genetically engineering cells; obtain cells, transform with preferential vector, recover transformed cells, propagate, monitor cells for preferential activity
07/01/2003US6586250 Method of PCR-based gene targeting
07/01/2003US6586249 Transferring nucleic acids into cells; obtain cells, incubate with nucleotide sequences, expose to voltage, recover transformed cells
07/01/2003US6586245 Antisense modulation of CD40 ligand expression
07/01/2003US6586244 Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3
07/01/2003US6586242 TAO protein kinases and methods of use therefor
07/01/2003US6586240 Nucleic acid encoding a fusion protein which comprises a fluorescent domain and a binding domain obtained from a protein; use for determining location and movement
07/01/2003US6586238 Enzymatic nucleic acids containing 5′-and or 3′-cap structures
07/01/2003US6586237 Compositions and methods for cloning nucleic acids
07/01/2003US6586236 Modulation of polypeptide display on modified filamentous phage use
07/01/2003US6586234 Internal surface is coated with capture nucleotide sequences which bind to target sequence to form hybridization complexes; sensitive and sequence specific assay for the diagnosis of disease and identification of pathogens
07/01/2003US6586229 Isolated nucleic acid fragment encoding genes involved in a bacterial toluene monooxygenase enzyme pathway; used as a monomer for synthesizing Liquid Crystal Polymers
07/01/2003US6586225 Nucleotide sequence coding enzymatic polypeptide; for use in the prevention of and treatment of nervous system and autoimmune disorders; for treatment of infections, alopecia and aging
07/01/2003US6586224 Decreased immunogenicity; use in cleaning and personal care compositions
07/01/2003US6586223 Subtilisin protease variants having amino acid substitutions in defined epitope regions
07/01/2003US6586221 Carbonyl hydrolase variants derived from the DNA sequences of naturally-occurring or recombinant non-human carbonyl hydrolases are disclosed. The variant carbonyl hydrolases, in general, are obtained by in vitro modification of a precursor
07/01/2003US6586220 Isolated DNA from Bacillus, encoding the enzymes
07/01/2003US6586217 Mammalian selenophosphate synthetase
07/01/2003US6586216 Modification of enzyme by substitution with non-native amino acids to reduce inhibition by purine nucleotide end products
07/01/2003US6586215 Polypeptides having peroxidase activity and nucleic acids encoding same
07/01/2003US6586214 Eliminating the intracellular activity of the enzyme through mutagenesis; used to increase the fermentative production of nucleotides, vitamins and amino acids, especially L-lysine
07/01/2003US6586211 Parallel synthesis of oligomeric building blocks; detaching from the support and bringing them in contact to synthesize DNA; directly converting genetic information into nucleic acids without using nucleic acid fragments already present
07/01/2003US6586210 Polynucleotides encoding T1 receptor like ligand II
07/01/2003US6586209 Xylanase production
07/01/2003US6586208 Controlling the generation of poisonous protein; obtain cell, transform with vector coding poisonous protein, express vector, recover protein
07/01/2003US6586207 Host cell is a methionine auxotroph; methionine-tRNA synthetase overexpressed in presence of analogues and absence of methionine; protein is modified dihydrofolate reductase
07/01/2003US6586206 Methods for making recombinant proteins using apoptosis inhibitors
07/01/2003US6586205 43239 a novel GPCR-like molecule and uses thereof
07/01/2003US6586203 ARF-P19, a novel regulator of the mammalian cell cycle
07/01/2003US6586202 Isoprenoid production
07/01/2003US6586197 Methods and materials for identifying novel pesticide agents
07/01/2003US6586193 Preferential detection of particle in sample; obtain sample, expose to light source, detect scattered light with eye, visibily scattered light indicates preferential particles in sample
07/01/2003US6586192 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
07/01/2003US6586191 Isolated nucleic acids encoding mammalian galanin receptors, isolated galanin receptor proteins, vectors comprising isolated nucleic acid encoding a mammalian galanin receptor, cells comprising such vectors, antibodies directed to a
07/01/2003US6586190 Parallel high throughput method and kit
07/01/2003US6586189 Screening method for PPAR-γ ligands
07/01/2003US6586185 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances
07/01/2003US6586184 Rearranging target nucleotide sequences; obtain cells, transfor with nucleotide sequences, detecting nucleotide sequences adjustment in prokaryotic cell
07/01/2003US6586182 Selecting amino acid sequence variations based on computer modeling; polynucleotides comprising subsequences of nucleic acids encoding the amino acid variations; reassembling into nucleotide sequences encoding mutagenized polypeptides
07/01/2003US6586181 Method for detecting allelic imbalance
07/01/2003US6586180 Directed antisense libraries
07/01/2003US6586179 Human Eag2
07/01/2003US6586177 Methods for disease detection
07/01/2003US6586176 Gel microdrops in genetic analysis
07/01/2003US6586175 Genotyping the human UDP-glucuronosyltransferase 2B7 (UGT2B7) gene
07/01/2003US6586174 Detecting CD8+ by contacting with culture of cells that contain recombinant DNA expression vector in which a reporter gene is associated with promoter sequence; measuring inhibition of reporter gene; can use in drugs for AIDS
07/01/2003US6586173 Antibodies; protecting animals from diseases caused by filariids; fluorescent or colorimetric tagged enzyme substrate
07/01/2003US6585976 Selected from Mycobacterium tuberculosis species and Mycobacterium bovis species, and wherein said strain is incapable of expressing the product of the active erp gene
07/01/2003US6585975 Use of Salmonella vectors for vaccination against helicobacter infection
07/01/2003US6585971 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
07/01/2003US6585968 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
07/01/2003US6585954 Method for searching steroid sulfatase inhibitors
07/01/2003CA2168037C Transformation systems for the yeast candida utilis and the expression of heterologous genes therewith
07/01/2003CA2123303C Icams immunoglobulin constant region soluble fusion proteins
07/01/2003CA2122338C Novel human cdc25 genes, encoded products and uses therefor
07/01/2003CA2086509C Non-cleavable soluble hybrid gp160 variant
07/01/2003CA2080548C Monoclonal antibodies to hepatitis c virus
07/01/2003CA2067469C Recombinant vaccine against marek's disease
07/01/2003CA2066387C Viral products
07/01/2003CA2046917C Polypeptides having thyrotropin-receptor activity, nucleic acid sequences coding for such receptors and polypeptides, and applications of these polypeptides
06/2003
06/27/2003CA2415012A1 Method for determining biospecies contained in test specimen and kit used for the same
06/26/2003WO2003052414A1 Screening method
06/26/2003WO2003052408A1 Method of screening drug
06/26/2003WO2003052142A2 Analysis and detection of multiple target sequences using circular probes
06/26/2003WO2003052141A2 High troughput analysis and detection of multiple target sequences using circular probes
06/26/2003WO2003052140A2 High throughput analysis and detection of multiple target sequences
06/26/2003WO2003052138A2 Methods of detecting modification of genetic material